CAR-T cell researchers optimistic about future of treating blood cancers
Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers.
Sep 15, 2023
0
40
Hemic and Lymphatic Diseases: News and Research on Hematologic Neoplasms
MeSH tree: C15.378.400
New study disentangles a long-standing link between inflammation and cancer progression
A new study published in Nature Genetics led by the Mead Group in the Radcliffe Department of Medicine has demonstrated a previously unknown effect of chronic inflammation on TP53-mutant hematopoietic stem cells.
Sep 8, 2023
0
253
New tool pinpoints gaps in awareness of blood cancer symptoms
A new tool could help identify gaps in the public's knowledge of blood cancer symptoms—helping to shape future awareness campaigns that could save countless lives.
Jul 14, 2023
0
24
COVID-19 booster vaccine doses strengthen immunity in blood cancer patients, shows study
Research by the University of Southampton into the effectiveness of COVID-19 vaccines in people with lymphoma has shown that repeated vaccination increases their ability to prevent infection from the virus, particularly after ...
Jul 3, 2023
0
152
Study uncovers role of ultraviolet radiation in development of rare leukemia in the skin
A change of scenery can restore one's outlook, but for some precancerous cells, a journey from the caves of the bone marrow to the sunny climes of the skin can trigger genetic changes that are a harbinger of cancer, according ...
Jun 7, 2023
0
53
Billions is spent on cancer research globally—but is it money well spent?
In 2020, 19 million people around the world received a cancer diagnosis. By 2040, that number is expected to reach 28 million. Poorer countries will be especially hard hit, with an increasing number of cases and more deaths, ...
Jun 2, 2023
0
123
Tunable bonds: A step towards targeted At-211 cancer therapy
Astatine is the least abundant element on Earth, and all of its known isotopes have a half-life of less than 8 hours. One astatine isotope, astatine-211 (At-211), emits alpha particles and shows promise as a cancer therapy. ...
May 31, 2023
0
47
Research shows that the bottom has been reached in restrictive blood transfusion policy
The trend in hospitals and guidelines is to be increasingly cautious with blood transfusions. Due to side effects associated with blood transfusion and the increasing scarcity and costs of blood products. For example, in ...
May 24, 2023
1
82
Researchers find link between obesity and blood cancer
Indiana University School of Medicine researchers studying clonal hematopoiesis of indeterminate potential (CHIP), a blood condition that may increase the risk of blood cancer, discovered that obesity was strongly associated ...
May 16, 2023
0
55
FDA approves cord blood stem cell product for blood cancer patients
The U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic cord blood-based cell therapy, to cut the risk of infection in patients with blood cancer following a myeloablative ...
Apr 24, 2023
0
53
